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Abstract
A revised allocation system for cadaveric kidney donations was introduced in Hong Kong in July
1996 to take into consideration the age and waiting time of patients on the waiting list for
transplantation, and the degree of HLA mismatch of the potential donor against the waiting patients.
In recognition of the established benefits of transplanting donor kidneys with zero mismatched
antigens against the recipient, the revised system provided that cadaveric kidneys would be
transplanted whenever possible to patients against whom the donor had zero mismatched antigens.
A total of 168 kidneys were allocated over a 45-month period using the revised system. The 3-year
actuarial graft survival was 83%, which exceeded the figure reported for the same population 3
years previously. It is concluded that the revised system is fulfilling its desired objective to remove
some older, long-term patients from the waiting list but that additional follow-up is required.
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INTRODUCTION
The difficulty of obtaining cadaveric organ donors in
Asian societies is well known. At any one time in Hong
Kong, approximately 1000 patients are on the waiting
list for cadaveric renal transplantation. As of 30 June
2000, 1022 patients were on the waiting list. In the 10
years from 1 January 1990 to 31 December 1999, an
average of only 40 cadaveric kidneys were transplanted
each year (range 31 to 58 per year). This major imbalance
between the number of patients on the waiting list and
the number of kidneys available results in considerable
difficulty in achieving a fair and equitable allocation of
cadaveric organs. To overcome this problem, we have
introduced a point score allocation system to take account
of the patient's age, length of time on the waiting list,
and HLA match with the donor. This paper documents
our experience with the revised point score system
between July 1996 and April 2000.
PATIENTS AND METHODS
During the period from 1 July 1996 to 30 April 2000, a
total of 168 cadaveric kidneys were available for
transplantation in Hong Kong. The kidneys were
allocated to 78 male recipients and 90 females. The
recipients had been on the waiting list for cadaveric
transplantation for periods ranging from 8 to 255 months
(mean 93.5; median 79.5). Follow-up time after
transplantation ranged from 1 to 44 months (mean 19.4;
median 20). Of the patients, 146 were followed for at
least 6 months. All donors were typed for HLA-A, -B,
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and -DR antigens in the Tissue Typing Laboratory at
Queen Mary Hospital as part of the pretransplant work-
up that forms the standard procedure throughout the SAR.
Wherever possible, kidneys were allocated to waiting
patients against whom the donor had no incompatible
antigens at either the HLA-A, -B, or -DR loci. If no
patients with a zero-antigen mismatch were identified,
kidneys were allocated according to a point score
calculated for each ABO blood group compatible patient
on the waiting list of the hospital cluster in which the
donor was identified. For the purposes of this calculation,
potential recipients were separated into four hospital
clusters corresponding to whether they were normally
treated in hospitals or dialysis units affiliated with Queen
Mary Hospital, Prince of Wales Hospital, Princess
Margaret Hospital or Queen Elizabeth Hospital.
Point scores were allocated according to the following
formula:
Point score = (60 - age of patient) + (years on waiting
list x 5) + (10 for patients below 15 years of age) + (HLA
score)
The HLA score was awarded as follows on the basis of
the number of HLA antigens in the potential donor that
were mismatched against the potential recipient:
20 if HLA-B and HLA-DR mismatch = 0
15 if HLA-B and HLA-DR mismatch = 1
10 if HLA-B and HLA-DR mismatch = 2
plus 5 extra if HLA mismatch = 0
As far as possible, kidneys were allocated to the patients
with the highest point score in the hospital cluster in
which the donor was identified. Regardless of point score,
however, patients were excluded from transplant if any
of the following conditions applied:-
1. The lymphocytotoxicity crossmatch against the
cadaveric donor was positive;
2. The patient had a current or previous history of
antibodies against incompatible HLA antigens present
in the donor;
3. The present donor shared an incompatible antigen
against the patient with a donor from a previous failed
transplant; and
4. Other clinical or social contraindications to transplant
were present.
RESULTS
The distribution of mismatched donor antigens in the
168 recipients is shown in figure 1. It may be seen that
18 kidneys were allocated to recipients for whom the
donor had no mismatched HLA antigens against the
recipient. The age distribution is shown in figure 2. The
recipient ages ranged from 8 to 60 years (mean 41.2;
median 42). The outcome of 146 recipients with at least
6 months post-transplant follow-up is shown in table 1.
The actuarial graft outcome of all 168 recipients is shown
in figure 3. The cause of death listed on the Hospital
Authority Transplant Registry is shown in table 2 for 16
patients who died at some stage after transplantation. In
only one of these cases was rejection listed as a
contributory cause of death. The patient survival time
following transplantation in the 16 patients who died
ranged from 0 to 34 months (median 4 months).
DISCUSSION
Before 1994, cadaveric kidneys in Hong Kong were
allocated predominantly on the basis of the number of
Figure 1.  Distribution of mismatched donor antigens in 168
cadaveric renal transplants.
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HLA antigens in common between the donor and patients
on the waiting list. As far as possible, kidneys would be
allocated to patients with the most antigens in common
with the donor. The number of HLA antigens in common,
based on a typical typing for HLA-A, HLA-B and HLA-
DR, could range from six to zero. Since for any particular
donor there would invariably be many recipients with
the same number of antigens in common, a secondary
method of selection was necessary. This method varied
from one hospital to another and included such criteria
as age (younger recipients were preferred), period of time
on the waiting list, clinical considerations, psychosocial
considerations, etc.
There was, therefore, some recognition that certain
patients may be more appropriate recipients than others
of a particular donated kidney. A 21-year-old patient,
for example, may be more appropriate as a recipient than
a 59-year-old because the younger patient would be
expected to live longer and therefore keep the kidney
longer. Alternatively, a 55-year-old who has been on the
waiting list for 15 years may be suffering more
complications from prolonged dialysis than a younger
patient and may be causing an excessive drain on
expensive resources. Transplantation of this patient may
not only improve the patient's quality of life but could
also result in a significant saving of resources.
Despite the recognition that age and waiting time were
important considerations in the allocation of cadaveric
Figure 2.  Age distribution of recipients of 168 cadaveric renal
transplants.
Table 1.  Outcome of 146 cadaveric transplants with at least 6
months follow-up.
Outcome Number %
Alive with functioning graft 114 78.1
Alive after graft failure 13 8.9
Deceased 16 11.0
No information 3 2.0
Total 146 100.0
Table 2.   Cause of death in 16 patients who died after
transplantation.
Cause Number
Lung infection 4
Cardiac arrest 3
Malignancy 2
Liver failure 1
CVA 1
Septicemia 2
Others 3
Figure 3.  Actuarial graft survival of 168 cadaveric renal transplants.
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kidneys, there was no unified system in place in the
territory to account for these factors prior to 1994. In
1994, the Central Renal Committee introduced a point
score allocation system to standardize the weighting of
age and waiting time.
Under the 1994 system, a point score was calculated as
follows:
Point score = (60 - age of patient) + (years on waiting
list x 3) + (5 for patients aged below 13 years of age)
Having ranked potential recipients in terms of the number
of HLA antigens in common with the donor, the point
score would be used to determine the ranking of patients
amongst those with the best HLA match.
The formula was devised empirically and was selected
from a number of models giving different weightings to
age and waiting time. It was also recognized that pediatric
and prepubertal patients have additional needs, and an
additional weighting for these patients was included in
the formula. Applying the formula to typical patients, a
24-year-old patient who had been on the waiting list for
4 years would qualify for 48 points, for example, while
a 56-year-old who had been on the waiting list for 15
years would qualify for 49 points. This system remained
in operation on an experimental basis for approximately
2 years.
During the trial period, there became increasing
awareness that allocation of kidneys strictly on the basis
of antigens in common with the donor has some
fundamental disadvantages. In particular, a potential
recipient with one or more uncommon HLA antigens is
unlikely to find a matched donor and will remain on the
waiting list for a long period. The concept of mismatched
antigens in the donor helps overcome this disadvantage
and more closely reflects the biological factors that
determine why a particular donor may be more suitable
or less suitable for a particular patient.
In terms of predicting possible graft rejection, it is
important to know what is present in the donor that is
not present in the recipient since it is this that ultimately
results in rejection of the transplanted organ. Various
examples to illustrate this concept are depicted in table
3, using data from a hypothetical donor and five
hypothetical patients. The donor has only DR15
detectable at the HLA-DR locus. This means, in all
probability, that the donor has inherited DR15 from both
of his parents and is therefore homozygous for DR15.
The same applies to patient 1 and patient 4.
Patient 1 has the same phenotype as the donor and
therefore has five antigens in common with the donor.
Conversely, the donor may be considered to have zero
antigens mismatched against the patient.
Comparing the donor with patient 2, it may be seen that
the donor has HLA-A11, which is not present in the
patient. The other antigens in the donor are also present
in the patient. The donor therefore has one incompatible
antigen (HLA-A11) against the patient. If a kidney from
this donor were to be transplanted to patient 2, the
incompatibility could ultimately lead to an immune
response by the recipient against the donated organ. The
fact that patient 2 has HLA-DR7, which is not present in
the donor, is of no relevance because the donor's immune
system will be unaffected by the DR7 in the patient.
Conversely, the fact that the patient has two HLA-DR
antigens identifiable while the donor has only one is not
relevant because it assumed that the donor had only HLA-
DR15 present, which will not result in an immunological
reaction by the recipient.
In the case of patient 5, it may be seen that the donor has
three antigens mismatched against the patient: A2, A11,
and B13. On balance, this patient would be expected to
have a greater risk of rejecting an organ from that donor
than would patient 2 because the level of mismatch is
higher.
In recognition of these considerations, and to fine-tune
the other weightings based on 2 years of experience, the
Central Renal Committee revised the allocation system
in 1996 to include a component representing the number
of mismatched HLA antigens in the donor. An additional
feature of the revised allocation system was that kidneys
Table 3.  Antigens in common versus antigens mismatched.
Antigens in common Antigens mismatched
Donor HLA A2, A11, B13, B75, DR15
Patient 1 HLA A2, A11, B13, B75, DR15 5  0
Patient 2 HLA A2, A33, B13, B75, DR15, DR7 4 1
Patient 3 HLA A2, B13, B46, DR15, DR9 3 2
Patient 4 HLA A24, A33, B13, B75, DR15 3 2
Patient 5 HLA A26, A33, B60, B75, DR15, DR4 2 3
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would be transferred out of the hospital cluster in which
the donor was identified if there was a patient in another
cluster against whom the donor had zero mismatched
HLA antigens. This decision reflected the well-
recognized benefits of transplanting zero mismatch
kidneys and followed the practice that had been in
operation in USA, Europe and Australasia for several
years.
The major departure from previous practice in Hong
Kong was the use of HLA matching as a contributory
factor in the allocation of kidneys rather than as the
primary determining factor. The score attributed to the
degree of HLA mismatching was calculated to reflect
the well known phenomenon that mismatches for HLA-
B and -DR have a greater impact on graft outcome than
mismatches for HLA-A. The distribution of the number
of mismatched HLA antigens in the donors following
the introduction of the revised system (Fig. 1) is
consistent with there having been no special selection
for the number of mismatches once the recipients with
zero mismatched antigens in the donor had been chosen.
Leaving aside the 18 patients with zero mismatches, the
distribution of the number of mismatched HLA antigens
in the donors showed a random distribution with 48.6%
having three mismatches or less and 51.4% with four
mismatches or more.
The revised allocation system apparently achieved its
aim to clear some of the older patients from the waiting
list. As shown in figure 2, 53% of recipients were above
the age of 40 years and 13% above 50 years. This is a
significant departure from the previous preference for
transplanting younger patients.
In order to evaluate the revised system fully, it is
necessary to determine whether there was any significant
change in the outcome of transplantation after the revised
system was introduced. The Kaplan Meier analysis
shown in figure 3 shows the typical pattern of accelerated
graft loss during the first 6 months followed by a leveling
off and only minimal graft loss thereafter. Graft survival
at the end of 3 years was 83%. Previously we have
reported on the outcome of 352 cadaveric kidney
transplants performed over a 25-year period in Hong
Kong and reported a 3-year actuarial graft survival of
76% (1). Hence, it is apparent that the revised allocation
system is not resulting in a worse outcome than was
obtained previously. A point of some concern is that 16
recipients died after transplantation (Table 1). In only
one case was rejection given as a contributory cause of
death. However, it is noteworthy that eight of the 16
patients died within 4 months of transplantation and it is
difficult without further information to exclude a
relationship between these deaths and the preceding
transplants.
Of the 18 patients who received kidneys with zero antigen
mismatches, one (5.6%) died after transplantation. By
convention, death after transplantation is regarded as
graft failure, even if the patient was known to have a
functioning graft at the time of death. Among the 150
patients who received a kidney with one or more antigens
mismatched there were 28 failures (13 patients surviving
and 16 deaths). This failure rate is not statistically
significant from that of the zero antigen mismatched
kidneys (x2 = 1.6; p < 0.2).
CONCLUSION
The point score system introduced in 1996 appears to be
achieving its aim of providing a fair and more equitable
method of allocating cadaveric kidneys than that which
existed previously. The system is reproducible and
provides an accountable basis for allocation. There
appears to have been an increase in the number of older
and long-term patients receiving transplants than was
observed previously. Significantly, 50% of the patients
transplanted had been on the waiting list for more than 6
years, the longest for over 21 years. In this respect the
new system must be considered successful.
Less impressively, it was noted that 9.5% of the
transplanted patients died within 34 months of the
transplant and that half of the deaths occurred within 4
months of the transplant. It will be necessary to monitor
this matter carefully over the next few years.
Under the new allocation system, less emphasis than
previously has been placed on HLA matching other than
to encourage the transplantation of patients against whom
the donors have no incompatible antigens. This does not
appear to have affected the overall outcome, and the
observed successful outcome of 83% at 3 years exceeds
the figure observed in the territory in a previous report.
There was no significant difference in the failure rate of
kidneys with zero mismatched antigens compared with
those with non-zero mismatches. This is not necessarily
of relevance, however, because it is well known that
much of the benefit of HLA matching is in long-term
rather than short-term outcome. Extended follow-up over
many years will be necessary to appreciate the full
benefits of the revised system.
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